20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Cellular targets for HIV infection
#2102Biotin-conjugated hexapeptide-2 derivative and use thereof
#2103Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations
#2104PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME
#2105Lactococcus lactis strains
#2106Peptidomimetic macrocycles
#2107Lactococcus lactis strains
#2108Cholecystokinin B receptor targeting for imaging and therapy
#2109Antiviral methods and compositions comprising probiotic bacterial molecules
#2110Organogels and emulsions for biological and non-biological applications
#2111Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers
#2112Methods and compositions for oral administration of melanocortin receptor agonist compounds
#2113Peptide pharmaceuticals
#2114Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
#2115Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
#2116METHODS OF INHIBITING THE GHRELIN/GROWTH HORMONE SECRETATOGUE RECEPTOR PATHWAY AND USES THEREOF
#2117Macrocyclic compounds for suppressing replication of hepatitis C virus
#2118Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
#2119PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#2120Antifungal agents and uses thereof
#2121PAR-1 activation by metalloproteinase-1 (MMP-1)
#2122Modulation of activity of proneurotrophins
#2123Skin cream
#2124Antitumor peptide and use thereof
#2125Methods for treating pain
#2126Methods of improving behavioral therapies
#2127Cosmetic use of an albizia julibrissin extract and corresponding topical composition
#2128INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER
#2129Netrin loop peptide mimetics and uses thereof
#2130Sincalide Formulations
#2131Peptoid oligomers, pharmaceutical compositions and methods of using the same
#2132Combination therapy for the treatment of cancer using an anti-C-met antibody
#2133Methods for the treatment of Prader-Willi-like syndrome or non-organic failure to thrive (NOFITT) feeding disorder using an agonist of the oxytocin receptor
#2134Amphiphilic peptides for treatment of keratitis
#2135METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS
#2136Elastin digest compositions and methods utilizing same
#2137Peptides for the Treatment of Hearing
#2138Methods and compositions related to targeting tumors and wounds
#2139Method for purification of Micafungin
#2140Methods for manufacturing an antifungal agent
#2141Peptides and methods and uses thereof for preventing retinal disorders
#2142Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications
#2143Ligands to radiation-induced molecules
#2144Method and pharmaceutical composition for hair growth
#2145Combination therapies using cyclosporine and aromatic cationic peptides
#2146Cytotoxic peptides and antibody drug conjugates thereof
#2147Peptide compounds for inhibition of platelet aggregation
#2148Antibodies specific for trop-2 and their uses
#2149Sustained release polymer
#2150Neurotrophic peptides for the treatment of tauopathies
#2151Beta-arrestin effectors and compositions and methods of use thereof
#2152Organic compounds and their uses
#2153Compositions for binding to amyloid proteins
#2154Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#2155Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions
#2156Methods for reducing oxidative damage
#2157Methods for treating metastatic stage prostate cancer
#2158Self-assembled composite ultrasmall peptide-polymer hydrogels
#2159Targeted antimicrobial moieties
#2160Robust controlled-release formulations
#2161TCL1 peptides for immunotherapy
#2162Compositions and methods for treating diseases
#2163Synthetic peptides for treatment of bacterial infections
#2164IAP BIR domain binding compounds
#2165β-arrestin effectors and compositions and methods of use thereof
#2166Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome
#2167Anti-inflammatory peptides and use thereof
#2168MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
#2169PREVENTION AND TREATMENT OF ACUTE INFLAMMATORY CONDITIONS
#2170Robust controlled-release peptide formulations
#2171Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#2172Peptide inhibiting matrix metalloproteanases activity and use thereof
#2173ORGANIC COMPOUNDS
#2174METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#2175METHOD AND COMPOSITIONS FOR TREATING STROKE WITH FEVER
#2176SUSTAINED-RELEASE MICROSPHERES AND METHODS OF MAKING AND USING SAME
#2177ANTAGONISTS OF MUC1
#2178Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
#2179Synthesis of libraries of peptide tertiary amides
#2180Methods and products for treating preeclampsia and modulating blood pressure
#2181CALCIMIMETICS AND METHODS FOR THEIR USE
#2182Methods related to the treatment of neurodegenerative and inflammatory conditions
#2183Compositions and methods for drug-sensitization or inhibition of a cancer cell
#2184Controlled-release peptide compositions and uses thereof
#2185COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#2186Immunogenic tumor associated stromal cell antigen peptides and methods of their use
#2187HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#2188ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF
#2189BIOMARKERS FOR HCV INFECTED PATIENTS
#2190Apoptosis-targeting nanoparticles
#2191Antisense antiviral compound and method for treating influenza viral infection
#2192Akt-specific capture agents, compositions, and methods of using and making
#2193Methods and compositions for treating pain
#2194Inhibitors of metastasis
#2195USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE
#2196Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
#2197NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#2198NOVEL A4B7 PEPTIDE ANTAGONISTS
#2199TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS
#2200PEPTIDOMIMETIC PROTEASE INHIBITORS
#2201Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders
#2202STABLE PHARMACEUTICAL FORMULATIONS OF GROWTH FACTOR PEPTIDES
#2203Compounds binding to the bacterial beta ring
#2204Peptide-presenting surfaces for long-term culture of pluripotent cells
#2205Agonists of guanylate cyclase and their uses
#2206METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION
#2207NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS
#2208METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS
#2209Cardiovascular disease treatment and prevention
#2210CARDIOVASCULAR DISEASE TREATMENT AND PREVENTION
#2211Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
#2212Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
#2213Nutritional compositions containing a peptide component and uses thereof
#2214Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#2215IFNγR2 compositions and methods of inhibiting neuronal cell death
#2216Methods for reducing CD36 expression
#2217Compositions and methods of treating gliomas
#2218DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDES OR THEIR INHIBITORS
#2219Antimicrobial peptides for treatment of infectious diseases
#2220Peptide nanoparticles and uses therefor
#2221THERAPIES FOR CHRONIC RENAL FAILURE USING ONE OR MORE INTEGRIN ANTAGONISTS
#2222Method of treatment or prophylaxis
#2223Peptides that target dorsal root ganglion neurons
#2224PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
#2225Method for treating chemotherapy-induced male infertility
#2226Cathepsin-binding compounds bound to a carrier and their diagnostic use
#2227Low impurity content caspofungin preparation, method for preparing same, and use thereof
#2228Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
#2229Skin rejuvenation cream
#2230Use of plant cell membrane treatment of obesity
#2231Use of plant cell membrane treatment of obesity
#2232Amphiphilic peptides and hydrogel matrices thereof for bone repair
#2233SMALL SURVIVAL-PROMOTING/IMMUNOMODULATORY PEPTIDE FOR TREATMENT OF BRAIN DAMAGE, NEURODEGENERATIVE DISORDERS, AND INFLAMMATORY DISORDERS
#2234CAPCNA peptide therapeutics for cancer
#2235Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients
#2236Stable peptide-based PACE4 inhibitors
#2237MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS
#2238Compositions and methods for treatment of cancer
#2239Therapeutic compounds for immunomodulation
#2240Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#2241Use of endostatin peptides for the treatment of fibrosis
#2242INDIBULIN THERAPY
#2243Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#2244Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#2245Peptides that stimulate subcutaneous adipogenesis
#2246Role of ADAM10 and its relevance to disease and therapeutics
#2247Retrograde transport peptide and use of same for delivery to central nervous system
#2248Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#2249Pharmaceutical composition
#2250Compositions and methods for treatment
#2251Therapeutic compositions and related methods
#2252Antimicrobial compositions and methods of use thereof
#2253Hydrogels with covalently linked polypeptides
#2254Inhibition of TREM receptor signaling with peptide variants
#2255Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation
#2256CETP fragments
#2257Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
#2258Compositions and methods for treatment of intracellular damage and bacterial infection
#2259Guanylylcyclase C ligands
#2260Method of treatment or prophylaxis of inflammatory pain
#2261Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
#2262Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#2263Spiro[2.4]heptanes for treatment of flaviviridae infections
#2264Spiro[2.4]heptanes for treatment of flaviviridae infections
#2265Methods for P2RY5 Mediated Regulation of Hair Growth and Mutants Thereof
#2266Antimicrobial peptides and uses therefore
#2267Small Peptides And Methods For Treatment Of Chronic Obstructive Pulmonary Disease
#2268Repairing Bruch's membrane with hydrogels
#2269Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
#2270Generation of new pancreatic beta cells
#2271Use of peptides for promoting wound healing
#2272Method of treating prostate cancer with GnRH antagonist
#2273Methods comprising desmopressin
#2274Combination therapy and kit for the prevention and treatment of cystic fibrosis
#2275Enopeptins, uses thereof, and methods of synthesis thereto
#2276Method for screening a glutamate release inhibitor in an astrocyte
#2277Amphiphilic linear peptidepeptoid and hydrogel comprising the same
#2278sGCalphal inhibiting compositions
#2279Anti-microbial peptides and uses of same
#2280PGC-1α-modulating peptides
#2281Uses of an immunomodulatory protein (GMI) from
#2282HYD1 PEPTIDES FOR RELAPSED CANCER
#2283Treatment of kidney fibrosis with VIP fragments
#2284BMP BINDING PEPTIDES
#2285Pharmaceutical composition and methods for peptide treatment
#2286Method of treating eosinophilia by administering an immunomodulating peptide
#2287COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#2288METHODS OF TREATING CANCER
#2289Peptides that are modulators of the protein TRF2 and compositions containing same
#2290TREATING DIABETES WITH OXYTOCIN OR OXYTOCIN ANALOGS
#2291Peptides and use thereof in the inhibition of angiotensin converting enzyme
#2292Sincalide Formulations
#2293Methods and devices for desmopressin drug delivery
#2294Compositions of A-8R peptide
#2295Treatment of cancers with A-8R peptide
#2296LLP2A-bisphosphonate conjugates for osteoporosis treatment
#2297INHIBITORS OF SERINE PROTEASES
#2298Compositions for inhibiting virus entry and promoting virolysis, and methods thereof
#2299Auristatin drug linker conjugates
#2300Methods and Compositions for Treating Conditions
#2301Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
#2302Methods of protecting against apoptosis using lipopeptides
#2303METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#2304Nanoparticles containing pH-responsive peptide
#2305Tissue occluding agent comprising an IEIKIEIKIEIKI peptide
#2306Compositions and methods for promoting wound healing and tissue regeneration
#2307Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same
#2308Peptidic activators of type I cGMP dependent protein kinases and uses thereof
#2309Therapeutic agents with improved fibrinogen binding
#2310NOVEL COMPOSITION FOR TUMOR GROWTH CONTROL
#2311SOLID PHARMACEUTICAL COMPOSITION
#2312TREATMENT OF MENSTRUAL PAIN AND EXCESSIVE MENSTRUAL BLOOD LOSS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF ANTIFIBRINOLYTIC OR HEMOSTATIC AGENT IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUG
#2313DISEASE INHIBITING AGENT
#2314Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
#2315Neuroprotective and neurorestorative methods and compositions
#2316ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (2)
#2317Methods of treating muscular wasting diseases using NF-KB activation inhibitors
#2318β-arrestin effectors and compositions and methods of use thereof
#2319Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
#2320Inhibition of MyBP-C binding to myosin as a treatment for heart failure
#2321Dimeric Smac Mimetics
#2322Boc and Fmoc solid phase peptide synthesis
#2323HYDROGEL COMPOSITIONS
#2324IAP antagonists
#2325Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis
#2326Methods and compositions for the treatment of axonal and neuronal degeneration
#2327METHODS FOR TREATING EARLY STAGE OR MILD NEUROLOGICAL DISORDERS
#2328PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
#2329Anti-ageing peptides modulating survivin and compositions including same
#2330PAR1 and PAR2 c-tail peptides and peptide mimetics
#2331HEXAPEPTIDE WITH IMPROVED ACTIVITY IN THE REPAIR OF CELLULAR DNA OF DERMAL CELLS
#2332METHODS FOR INCREASING INSULIN SENSITIVITY AND TREATING DIABETES WITH A BIOACTIVE CHROMIUM BINDING PEPTIDE
#2333Methods of treating cancer
#2334METHODS FOR INDUCING EPITHELIAL CANCER CELL SENESCENCE
#2335Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
#2336SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION
#2337Aminostatin derivatives for the treatment of arthrosis
#2338Lipid nanoparticle compositions for antisense oligonucleotides delivery
#2339KIT AND METHOD OF USE OF TARGETING PEPTIDE FOR DIAGNOSIS AND THERAPY OF CANCER
#2340Histatin for Corneal Wound Healing and Ocular Surface Disease
#2341Histatin for Corneal Wound Healing and Ocular Surface Disease
#2342Glycogen synthase kinase-3 inhibitors
#2343STABLE READY-TO-USE CETRORELIX INJECTION
#2344OCTREOTIDE INJECTION
#2345Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor
#2346Method of treating age-related macular degeneration comprising administering a compstatin analog
#2347Method of treating inflammatory bowel disease by administering a clip-inducing agent
#2348THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA
#2349Inhibitors of apoptosis and uses thereof
#2350Dermatopontin-activating peptides and cosmetic compositions including same
#2351Use of peptides for promoting wound healing
#2352Methods for treating steatotic disease
#2353USE OF TIGHT JUNCTION ANTAGONISTS IN THE TREATMENT OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS
#2354Process for the manufacture of Degarelix and its intermediates
#2355Process for the manufacture of Degarelix and its intermediates
#2356Larazotide acetate compositions
#2357Broad spectrum antibiotic arylomycin analogs
#2358Viral polymerase inhibitors
#2359Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#2360Compositions and methods for promoting wound healing and tissue regeneration
#2361Anti-SSX-2 T cell receptors and related materials and methods of use
#2362Treating MUC1-expressing cancers with combination therapies
#2363METHOD FOR TREATMENT OF INFLAMMATORY DISEASE AND DISORDER
#2364Viral polymerase inhibitors
#2365Active cores of peptide triazole HIV-1 entry inhibitors
#2366Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
#2367Treatment of penetrative injury to the brain
#2368Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (DCIR) activity and signaling events
#2369Moesin modulators and uses thereof
#2370N-carboxyalkyl-auristatin and the use thereof
#2371Ligands to radiation-induced molecules
#2372VIP fragments and methods of use
#2373BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACTAM ANTIBACTERIALS
#2374USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE
#2375Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154
#2376Synergistic anti-proliferation activity of TAS-108 with mTOR inhibitors against cancer cells
#2377METHODS AND COMPOSITIONS FOR PROSTATE CANCER IMMUNOTHERAPY
#2378Immunostimulatory method
#2379Combination therapy with WT1 peptide vaccine and temozolomide
#2380Hydrogel nanocomposite wound dressing and a method of synthesizing the same
#2381Linear peptide antibiotics
#2382PENTAPEPTIDE DERIVATIVES FOR PROMOTING HAIR GROWTH
#2383Azapeptides as CD36 binding compounds
#2384Methods for treatment of pain
#2385PHARMACEUTICAL COMPOSITION FOR TREATING MEDICAL CONDITIONS AND A METHOD FOR TREATING ALIMENTARY DISORDERS AND RELATED DISEASES
#2386Beta-arrestin effectors and compositions and methods of use thereof
#2387CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders
#2388TREATING SURFACE OF THE EYE DISORDERS
#2389METHODS TO INHIBIT NEURODEGENERATION
#2390HIGH POTENCY FORMULATIONS OF VX-950
#2391Synthetic bile acid compositions and methods
#2392Peptides, derivatives and analogs thereof, and methods of using same
#2393PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAME
#2394Compositions and methods for promoting wound healing and tissue regeneration
#2395Use of armillaridin for treating cancer
#2396Growth hormone secretatogue receptor antagonists and uses thereof
#2397Octreotide-modified nanomedicine for cancer treatment or cancer palliative care
#2398Modulation of activity of neurotrophins
#2399Auristatin derivatives and use thereof
#2400Novel Peptides for Wound Healing